Cargando…
Mechanism and consequences of RAF kinase activation by small-molecule inhibitors
Despite the clinical success of RAF inhibitors in BRAF-mutated melanomas, attempts to target RAF kinases in the context of RAS-driven or otherwise RAF wild-type tumours have not only been ineffective, but RAF inhibitors appear to aggravate tumorigenesis in these settings. Subsequent preclinical inve...
Autores principales: | Holderfield, M, Nagel, T E, Stuart, D D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4134487/ https://www.ncbi.nlm.nih.gov/pubmed/24642617 http://dx.doi.org/10.1038/bjc.2014.139 |
Ejemplares similares
-
Targeting the Raf kinases in human cancer: the Raf dimer dilemma
por: Durrant, David E, et al.
Publicado: (2018) -
Small-Molecule Inhibitors of Chikungunya Virus: Mechanisms of Action and Antiviral Drug Resistance
por: Kovacikova, Kristina, et al.
Publicado: (2020) -
Ras and Raf pathways in epidermis development and carcinogenesis
por: Kern, F, et al.
Publicado: (2011) -
Conferring specificity on the ubiquitous Raf/MEK signalling pathway
por: O'Neill, E, et al.
Publicado: (2004) -
Small‐Molecule and Peptide Inhibitors of the Pro‐Survival Protein Mcl‐1
por: Beekman, Andrew M., et al.
Publicado: (2015)